CLINICAL OUTCOME EVALUATION AND PROGNOSIS OF ICU-ADMITTED DRUG ABUSE
Main Article Content
Keywords
Drug abuse, ICU, mortality, mechanical ventilation, opioids, clinical outcomes
Abstract
Background: Substance abuse is a significant global issue, leading to severe health complications that often necessitate intensive care unit (ICU) admission. The prognosis of ICU-admitted drug abuse patients remains a critical area for study, given the high morbidity and mortality associated with this population.
Objectives: To evaluate the clinical outcomes and identify predictors of mortality in ICU-admitted patients with drug abuse.
Study Design and Setting: This was a prospective observational study ICU of Liaquat University of Medical and Health Sciences, Jamshoro
Methodology: Patients aged 18 years and older, diagnosed with drug abuse and admitted to the ICU, were included in the study. Data were collected on demographics, type of substance abused, clinical interventions (mechanical ventilation, renal replacement therapy), length of ICU stay, and mortality. Multivariate logistic regression was used to identify predictors of mortality..
Results: The mean age of the patients was 38.5 ± 11.2 years, with 54.8% being male. Opioid abuse was the most common (32.6%), followed by alcohol (25.2%). The mean ICU stay was 6.7 ± 3.1 days, with 45.9% of patients requiring mechanical ventilation and 20.0% needing renal replacement therapy. The overall mortality rate was 25.2%. Logistic regression did not identify any statistically significant predictors of mortality.
Conclusion: ICU admission due to drug abuse results in considerable morbidity, but no significant predictors of mortality were identified in this study. Further research is warranted to improve the prediction of outcomes in this patient population.
References
2. Peprah E, Myers B, Kengne AP, Peer N, El-Shahawy O, Ojo T, Mukasa B, et al. Using a syndemics framework to understand how substance use contributes to morbidity and mortality among people living with HIV in Africa: a call to action. International journal of environmental research and public health. 2022 Jan 19;19(3):1097-07.
3. Bekele Z, Jisha H, Haile M. Outcomes and associated factors among adult patients admitted to adult intensive care unit, retrospective cohort study. IJS Oncology. 2022 Jan 1;7(1):20-9.
4. Martini F, Fregna L, Bosia M, Perrozzi G, Cavallaro R. Substance-related disorders. InFundamentals of Psychiatry for Health Care Professionals 2022;65(5):263-295).
5. Grzebinski S, Stein L, Dhamoon MS. Characteristics and outcomes of hospitalizations and readmissions for opioid dependence and overdose: nationally representative data. Substance Abuse. 2021 Oct;42(4):654-61.
6. Shlipak MG, Tummalapalli SL, Boulware LE, Grams ME, Ix JH, Jha V, Kengne AP, Madero M, Mihaylova B, Tangri N, Cheung M. The case for early identification and intervention of chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney international. 2021 Jan 1;99(1):34-47.
7. Sahu T, Pande B, Manasa PL, Verma HK. Liver dysfunction during COVID-19 pandemic: Contributing role of associated factors in disease progression and severity. World Journal of Hepatology. 2022;14(6):109-115.
8. Gold SM, Köhler-Forsberg O, Moss-Morris R, Mehnert A, Miranda JJ, Bullinger M, Steptoe A, Whooley MA, Otte C. Comorbid depression in medical diseases. Nature Reviews Disease Primers. 2020 Aug 20;6(1):69-73.
9. Adams CO, Joseph E, Ekele E, Rasong E, Obi D. Assessment Of Knowledge And Awareness Of Acute Physiology And Chronic Health Evaluation (APACHE) II Tool Among Intensive Care Nurses In A Tertiary Institution. International Journal of Anesthesia and Clinical Medicine. 2020;8(2):47-54.
10. Kumar V. Prognostic Scoring System In ICU. International Journal. 2022 Jul;5(4):10.
11. Essam Eldin R, Othman H, Salah Eldin H. Evaluation of Substance Abuse Cases Admitted in ICU of Poison Control Center-Ain Shams University Hospitals by Certain Clinical Scoring Systems. Ain Shams Journal of Forensic Medicine and Clinical Toxicology. 2021 Jan 1;36(1):90-7.
12. Vigneron C, Charpentier J, Valade S, Alexandre J, Chelabi S, Palmieri LJ, Franck N, Laurence V, Mira JP, Jamme M, Pène F. Patterns of ICU admissions and outcomes in patients with solid malignancies over the revolution of cancer treatment. Annals of Intensive Care. 2021 Dec;11:1-0.
13. Bekele Z, Jisha H, Haile M. Outcomes and associated factors among adult patients admitted to adult intensive care unit, retrospective cohort study. IJS Oncology. 2022 Jan 1;7(1):20-9.
14. Qadri RA, Sidiq S, Jehangir M, Mir AH, Khan T, Mir AW, Khan M. Clinical Profile and Outcome of Drug Abuse Patients Admitted in Intensive Care Unit of a Tertiary Care Hospital in Kashmir: A Prospective Observational Study. Prof. SK Dhattarwal. 2021 Jan;18(1):103.
15. Noor F, Samiullah. Pattern of drug abuse in Kashmir and role of forensics: an immediate need to act and introspect. Indian internet journal offorensic medicine and toxicology2015;13(3); 49-54
16. Bilge A. Evaluation of patients admitted to intensive care unit with drug intoxication: retrospective analysis of 203 patients. East J Med. 2023;29(1):767-71.
17. Mittal N, Verma M, Siwach S, Bansal P, Singhal SK. Drug Utilization Research and Predictors of Outcomes in the Intensive Care Unit of a Tertiary Care Hospital: A Prospective Observational Study. Cureus. 2022 Jan;15(12).
18. Drug utilization pattern in the intensive care unit of a tertiary care hospital. Biswal S, Mishra P, Malhotra S, Puri GD, Pandhi P. J Clin Pharmacol. 2016;46:945–951.
19. Review of antibiotic drug use in a surgical ICU: management with a patient data management system for additional outcome analysis in patients staying more than 24 hours. Hartmann B, Junger A, Brammen D, et al. Clin Ther. 2014;26:915–924.
20. Drug utilization pattern in an intensive care unit at a tertiary care teaching hospital in Oman. AL-Zakwani I, AL-Thuhli M, AL-Hashim A, AL Balushi KA. Asian J Pharm Clin Res. 2017;10:194–197
21. Bobek MB, Hoffman-Hogg L, Bair N, Slomka J, Mion LC, Arroliga AC. Utilization patterns, relative costs, and length of stay following adoption of MICU sedation guidelines. Formulary. 2020 Sep 1;36(9):664-.